Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term

Zacks Investment Research highlights HCA Healthcare (HCA) as a compelling momentum stock, noting its 'A' Momentum Style Score and a 7.4% share price increase over the past four weeks. The assessment is further supported by nine analysts raising their fiscal 2025 earnings estimates in the last 60 days, increasing the Zacks Consensus Estimate to $25.29 per share, and HCA's average earnings surprise of 7.1%.

Analysis

HCA Healthcare (HCA), the largest non-governmental operator of acute care hospitals in the United States, currently holds a Zacks Rank #3 (Hold), yet exhibits compelling characteristics for momentum-oriented investors. The company has secured an 'A' for its Momentum Style Score and an 'A' for its comprehensive VGM Score, indicating strength in momentum alongside favorable value and growth attributes. This is supported by a tangible 7.4% increase in HCA's share price over the past four weeks. Analyst sentiment is also reinforcing this positive momentum, with nine analysts having revised their fiscal 2025 earnings estimates upwards in the last 60 days. This collective action has driven the Zacks Consensus Estimate for fiscal 2025 earnings per share up by $0.34 to $25.29. Furthermore, HCA has demonstrated a consistent pattern of outperformance, boasting an average earnings surprise of 7.1%, which suggests robust operational capabilities and potential for continued positive financial results.

Key Decisions for Investors

• Investors focusing on momentum strategies should take note of HCA's 'A' Momentum Style Score, its recent 7.4% share price appreciation, and the positive revisions to its fiscal 2025 earnings consensus estimate, now at $25.29 per share.
• While the Zacks #3 (Hold) rank suggests a neutral near-term outlook, the strong 'A' VGM Score and consistent 7.1% average earnings surprise indicate underlying strengths that warrant placing HCA on a watchlist for potential re-evaluation should the overall rank improve.
• Consider allocating to HCA if portfolio strategy aligns with capturing upside from stocks exhibiting strong momentum and positive earnings estimate revisions, but weigh this against the current Hold rating by conducting further due diligence on broader valuation and sector trends.